Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-11-006994
Filing Date
2011-11-04
Accepted
2011-11-04 16:25:56
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 c67392_10-q.htm 10-Q 416691
2 c67392_ex31-1.htm EX-31.1 7950
3 c67392_ex32-1.htm EX-32.1 3601
  Complete submission text file 0000930413-11-006994.txt   2425251

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE enzn-20110930.xml EX-101.INS 408564
5 enzn-20110930.xsd EX-101.SCH 18554
6 XBRL CALCULATION FILE enzn-20110930_cal.xml EX-101.CAL 29570
7 XBRL DEFINITION FILE enzn-20110930_def.xml EX-101.DEF 88277
8 XBRL LABEL FILE enzn-20110930_lab.xml EX-101.LAB 125188
9 XBRL PRESENTATION FILE enzn-20110930_pre.xml EX-101.PRE 101678
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12957 | Film No.: 111181437
SIC: 2836 Biological Products, (No Diagnostic Substances)